Foley Todd Insider Trading -- Recent SEC Form 4 Transactions

Name: Foley Todd Insider Trading -- SEC Form 4 Transactions
Creator: ko.io

Foley Todd (CIK 1473930) reported 19 SEC Form 4 insider transactions across 4 companies over the past 18 months (most recent 2026-09-09). Recent activity: Sell TRDA (38,500 shares), Sell TRDA (192,500 shares), Sell TRDA (28,837 shares), Sell TRDA (29,088 shares), Sell TRDA (25,131 shares). Source: SEC Form 4.

Date	Company	Role	Type	Shares	Value
2026-09-09	Entrada Therapeutics, Inc. (TRDA)	10% Owner	Sell	38,500	$273,735
2026-09-09	Entrada Therapeutics, Inc. (TRDA)	10% Owner	Sell	192,500	$1.4M
2026-09-09	Entrada Therapeutics, Inc. (TRDA)	10% Owner	Sell	28,837	$205,608
2026-09-03	Entrada Therapeutics, Inc. (TRDA)	10% Owner	Sell	29,088	$205,361
2026-09-03	Entrada Therapeutics, Inc. (TRDA)	10% Owner	Sell	25,131	$180,692
2026-09-03	Entrada Therapeutics, Inc. (TRDA)	10% Owner	Sell	32,263	$231,326
2026-08-31	Entrada Therapeutics, Inc. (TRDA)	10% Owner	Sell	38,922	$280,238
2026-08-31	Entrada Therapeutics, Inc. (TRDA)	10% Owner	Sell	3,733	$26,168
2026-08-31	Entrada Therapeutics, Inc. (TRDA)	10% Owner	Sell	44,259	$309,370
2026-08-26	Entrada Therapeutics, Inc. (TRDA)	10% Owner	Sell	21,623	$158,713
2026-08-26	Entrada Therapeutics, Inc. (TRDA)	10% Owner	Sell	26,522	$199,976
2026-08-26	Entrada Therapeutics, Inc. (TRDA)	10% Owner	Sell	14,569	$102,857
2026-01-14	Aktis Oncology, Inc. (AKTS)	Director	Buy	597,391	$0
2026-01-14	Aktis Oncology, Inc. (AKTS)	Director	Buy	2.7M	$0
2026-01-14	Aktis Oncology, Inc. (AKTS)	Director	Buy	716,872	$0
2026-01-14	Aktis Oncology, Inc. (AKTS)	Director	Buy	232,870	$4.2M
2025-05-15	iTeos Therapeutics, Inc. (ITOS)	Insider	Sell	630,191	$5.1M
2025-04-30	Werewolf Therapeutics, Inc. (HOWL)	10% Owner	Buy	22,758	$2,048
2025-04-30	Werewolf Therapeutics, Inc. (HOWL)	10% Owner	Sell	1,963	$2,061

来源：SEC Form 4 申报文件 · 截至 2026-09-09